PNC Financial Services Group’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $191K | Sell |
4,065
-2,324
| -36% | -$109K | ﹤0.01% | 2243 |
|
2025
Q1 | $282K | Buy |
6,389
+677
| +12% | +$29.9K | ﹤0.01% | 1942 |
|
2024
Q4 | $206K | Sell |
5,712
-662
| -10% | -$23.9K | ﹤0.01% | 2190 |
|
2024
Q3 | $204K | Buy |
6,374
+1,259
| +25% | +$40.3K | ﹤0.01% | 2157 |
|
2024
Q2 | $193K | Buy |
5,115
+4,990
| +3,992% | +$188K | ﹤0.01% | 2173 |
|
2024
Q1 | $6.15K | Buy |
125
+97
| +346% | +$4.78K | ﹤0.01% | 3899 |
|
2023
Q4 | $1.02K | Buy |
28
+18
| +180% | +$657 | ﹤0.01% | 4312 |
|
2023
Q3 | $231 | Hold |
10
| – | – | ﹤0.01% | 4524 |
|
2023
Q2 | $262 | Hold |
10
| – | – | ﹤0.01% | 4643 |
|
2023
Q1 | $257 | Hold |
10
| – | – | ﹤0.01% | 4577 |
|
2022
Q4 | $260 | Sell |
10
-198
| -95% | -$5.15K | ﹤0.01% | 4610 |
|
2022
Q3 | $5K | Buy |
+208
| New | +$5K | ﹤0.01% | 3979 |
|
2021
Q2 | – | Sell |
-21
| Closed | -$2K | – | 4285 |
|
2021
Q1 | $2K | Buy |
21
+4
| +24% | +$381 | ﹤0.01% | 3975 |
|
2020
Q4 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 3920 |
|